CCR Monthly Approval Report – December 2017

Products from HSBC, Lyxor, Aberdeen and others won approval, as did the first alternatives products from Carlyle Group, Oaktree Capital and Intermediate Capital Group.

This content is reserved for our licensees.

Log In Register

Alternatives registration already underway in Chile

Managers that already have investments via feeder funds can submit their approval directly, while new firms will have to gain sponsorship from an AFP.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – November 2017

iShares, Oddo, Matthews , Lyxor, and Edmond de Rothschild were the fund sponsors gaining approval for new products.

This content is reserved for our licensees.

Log In Register

CCR delists commodities products in response to new alternative-investment regime

The risk-rating agency responded to new rules put in place by the Pension authority, whose superintendent. Osvaldo Macías, said: "Investment in commodities will not be allowed at this stage by any modality, or investment in hedge funds."

This content is reserved for our licensees.

Log In Register

Chilean market approves of investment limits on alternatives

The more aggressive multifunds will eventually be able to allocate up to 15% of their assets to alternatives; however, initially the Central Bank is allowing a maximum of 10% in the type A fund.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – October 2017

While First Trust led with four ETFs registered in the month, while AllianceBernstein, Axa, LarrainVial and Credicorp Capital also won approval for funds of their own.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – September 2017

Eurizon led with three mutual funds registered in the month, all of them domiciled in Luxembourg, followed by PineBridge and UBAM, each with two funds approved.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – August 2017

Investec and Morgan Stanley had two products each registered, while JP Morgan and Lord Abbett followed completed the list with one fund each.

This content is reserved for our licensees.

Log In Register

HMC adds Aegon-owned Kames Capital to brand lineup

Ricardo Morales, a partner at HMC Capital, believes Kames brings a unique investment outlook to the Chilean market, as well as to HMC, which already reps for Matthews Asia, Neuberger Berman, Man and Bradesco.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – July 2017

Only three products were added in the month from three different asset managers: HSBC, Macquarie and Kames Capital.

This content is reserved for our licensees.

Log In Register